NPI: 1013190792 · PHOENIX, AZ 85004 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/17/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 12/17/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 29,874 | $635K |
| 2019 | 31,729 | $811K |
| 2020 | 23,409 | $624K |
| 2021 | 25,270 | $978K |
| 2022 | 24,584 | $920K |
| 2023 | 13,723 | $737K |
| 2024 | 7,855 | $688K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 60,002 | 4,769 | $5.04M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 659 | 351 | $352K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 30,962 | 2,597 | $2K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 132 | 48 | $1K |
| A4657 | Syringe, with or without needle, each | 18,134 | 3,183 | $980.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 25,303 | 2,065 | $30.72 |
| 90674 | 216 | 193 | $28.13 | |
| G0008 | Administration of influenza virus vaccine | 324 | 288 | $16.58 |
| 85041 | 1,534 | 1,352 | $0.00 | |
| 83540 | 1,307 | 1,141 | $0.00 | |
| 85048 | 1,505 | 1,328 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 8,454 | 1,977 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 3,966 | 322 | $0.00 |
| 82108 | 143 | 120 | $0.00 | |
| 83970 | 1,045 | 899 | $0.00 | |
| 90661 | 16 | 15 | $0.00 | |
| 90662 | 61 | 48 | $0.00 | |
| 83550 | 1,284 | 1,123 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 572 | 485 | $0.00 |
| 82728 | 629 | 549 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 183 | 115 | $0.00 |
| 90747 | 13 | 13 | $0.00 |